CCM
NUTX

Capstone Capital Management’s Nutex Health NUTX Stock Holding History

Capstone Capital Management’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,715
Closed -$282K – 92
2025
Q4 		$282K Buy
+1,715
New +$227K 0.27% 86

Other funds holding NUTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return

Capstone Capital Management's NUTX Position: Q1 2026 in Review

Capstone Capital Management sold out of Nutex Health (NUTX) in Q1 2026, closing a stake of 1,715 shares — an estimated $282K sold.

Capstone Capital Management first reported a position in NUTX in Q4 2025 and held it in 1 quarter. The position peaked at $282K in Q4 2025. 130 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Capstone Capital Management reported no remaining Nutex Health position as of Q1 2026 after selling out during the quarter.
  • Capstone Capital Management sold 1,715 Nutex Health shares in Q1 2026, an estimated $282K.
  • Capstone Capital Management first reported a position in Nutex Health in Q4 2025 and held it in 1 quarter.
  • Capstone Capital Management's Nutex Health position peaked at $282K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Capstone Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.